Pathologic Response During Chemo-radiotherapy and Variation of Serum VEGF Levels Could Predict Effects of Chemo-Radiotherapy in Patients with Esophageal Cancer |
Yu, Jing-Ping
(Department of Radiation Oncology, Changzhou NO.2 People's Hospital)
Lu, Wen-Bin (Department of Radiation Oncology, Changzhou NO.2 People's Hospital) Wang, Jian-Lin (Department of Radiation Oncology, Changzhou NO.2 People's Hospital) Ni, Xin-Chu (Department of Radiation Oncology, Changzhou NO.2 People's Hospital) Wang, Jian (Department of Radiation Oncology, Changzhou NO.2 People's Hospital) Sun, Zhi-Qiang (Department of Radiation Oncology, Changzhou NO.2 People's Hospital) Sun, Su-Ping (Department of Radiation Oncology, Changzhou NO.2 People's Hospital) |
1 | Angelescu C, Burada F, Ioana M, et al (2013). VEGF-A and VEGF-B mRNA expression in gastro-oesophageal cancers. Clin Transl Oncol, 15, 313-20. DOI |
2 | Brun E, Zatterstrom U, Kjellen E, et al (2001). Prognostic value of histopathological response to radiotherapy and microvessel density in oral squamous cell carcinomas. Acta Oncol, 40, 491-6. DOI |
3 | Cellini F, and Valentini V (2014). Targeted therapies in combination with radiotherapy in oesophageal and gastroesophageal carcinoma. Curr Med Chem, 21, 990-1004. DOI |
4 | Crehange G, Maingon P, Peignaux K, et al (2007). Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: Federation Francophone de Cancerologie Digestive 9102. J Clin Oncol, 25, 4895-901. DOI |
5 | Jiang JT, Zhang LF, Zhou B, et al (2012). Relationships of uPA and VEGF expression in esophageal cancer and microvascular density with tumorous invasion and metastasis. Asian Pac J Cancer Prev, 13, 3379-83. DOI ScienceOn |
6 | Limaverde-Sousa G, Sternberg C, and Ferreira CG (2014). Antiangiogenesis beyond VEGF inhibition: a journey from antiangiogenic single-target to broad-spectrum agents. Cancer Treat Rev, 40, 548-57. DOI |
7 | Liu J, Huang XE (2014). Efficacy of bifidobacterium tetragenous viable bacteria tablets for cancer patients with functional constipation. Asian Pac J Cancer Prev, 15, 10241-4. |
8 | Ou GF, Wang M, Wang LH, et al (2003). [Relation between pathologic tumor response to preoperative radiotherapy and the prognosis in patients with esophageal carcinoma]. Zhonghua Zhong Liu Za Zhi, 25, 278-81. |
9 | Peng J, Shao N, Peng H, and Chen LQ (2013). Prognostic significance of vascular endothelial growth factor expression in esophageal carcinoma: a meta-analysis. J BUON, 18, 398-406. |
10 | Qian YD, Xu X, Wang L, et al (2014). Clinical safety of chemotherapy for elderly cancer patients complicated with hypertension. Asian Pac J Cancer Prev, 15, 9875-7. DOI |
11 | Shibata Y, Haruki N, Kuwabara Y, et al (2002). Chfr expression is downregulated by CpG island hypermethylation in esophageal cancer. Carcinogenesis, 23, 1695-9. DOI |
12 | Srivastava VK, Gara RK, Rastogi N, et al (2014). Serum vascular endothelial growth factor-A (VEGF-A) as a biomarker in squamous cell carcinoma of head and neck patients undergoing chemoradiotherapy. Asian Pac J Cancer Prev, 15, 3261-5. DOI |
13 | Stahl M, Walz MK, Stuschke M, et al (2009). Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol, 27, 851-6. DOI ScienceOn |
14 | Tian GY, Miu M, Huang XE (2014).Systematic analysis of pemetrexed-based chemoradiotherapy for patients with locally advanced or metastatic esophageal cancer. Asian Pac J Cancer Prev, 15, 8475-8. DOI |
15 | Wang W, Sun QK, He YF, et al (2014). Overexpression of periostin is significantly correlated to the tumor angiogenesis and poor prognosis in patients with esophageal squamous cell carcinoma. Int J Clin Exp Pathol, 7, 593-601. |
16 | Yu J, Liu F, Sun Z, et al (2011). The enhancement of radiosensitivity in human esophageal carcinoma cells by thalidomide and its potential mechanism. Cancer Biother Radiopharm, 26, 219-27. DOI |
17 | Xiao Y, Liu J, Huang XE, et al (2014).Clinical study on fluvoxamine combined with oxycodone prolonged-release tablets in treating patients with moderate to severe cancer pain. Asian Pac J Cancer Prev, 15, 10445-9. |
![]() |